A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 172 shares of PCRX stock, worth $3,496. This represents 0.0% of its overall portfolio holdings.

Number of Shares
172
Previous 172 -0.0%
Holding current value
$3,496
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$25.5 - $31.51 $157,513 - $194,637
-6,177 Reduced 97.29%
172 $4,000
Q1 2024

May 09, 2024

SELL
$27.7 - $35.48 $7,839 - $10,040
-283 Reduced 4.27%
6,349 $185,000
Q4 2023

Feb 08, 2024

BUY
$26.32 - $34.31 $40,243 - $52,459
1,529 Added 29.96%
6,632 $223,000
Q3 2023

Nov 07, 2023

BUY
$30.68 - $40.09 $13,437 - $17,559
438 Added 9.39%
5,103 $156,000
Q2 2023

Aug 09, 2023

BUY
$36.12 - $47.5 $18,529 - $24,367
513 Added 12.36%
4,665 $186,000
Q1 2023

May 08, 2023

BUY
$35.53 - $43.38 $14,247 - $17,395
401 Added 10.69%
4,152 $169,000
Q4 2022

Feb 07, 2023

BUY
$38.19 - $57.45 $31,353 - $47,166
821 Added 28.02%
3,751 $144,000
Q3 2022

Nov 01, 2022

BUY
$51.24 - $58.89 $10,401 - $11,954
203 Added 7.44%
2,930 $156,000
Q2 2022

Aug 04, 2022

SELL
$51.49 - $81.64 $71,056 - $112,663
-1,380 Reduced 33.6%
2,727 $159,000
Q1 2022

May 09, 2022

BUY
$60.03 - $76.49 $15,307 - $19,504
255 Added 6.62%
4,107 $313,000
Q4 2021

Feb 07, 2022

BUY
$47.97 - $62.21 $184,780 - $239,632
3,852 New
3,852 $236,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $932M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.